Analysed INHIBRX BIOSCIENCES INC (INBX:NASDAQ) News Sources
Inhibrx Reports Interim Phase 2 Data for INBRX-106 in First-Line HNSCC; Initial Results Demonstrate Potential Costimulatory Benefit Over PD-1 Monotherapy
11-05-2026
yahoo.com
Inhibrx Biosciences’ INBRX-106 Combo Tops KEYTRUDA Alone in Phase 2 Cancer Study
11-05-2026
marketbeat.com
Should Positive INBRX-106 Phase 2 Head and Neck Data Require Action From Inhibrx Biosciences (INBX) Investors?
12-05-2026
yahoo.com
Inhibrx Biosciences (INBX) Announces Positive Interim Results From Phase 2 Portion of HexAgon Study
14-05-2026
yahoo.com
Inhibrx Announces U.S. FDA Acceptance of BLA for Ozekibart in Patients with Conventional Chondrosarcoma
15-06-2026
yahoo.com
Are You Looking for a Top Momentum Pick? Why Inhibrx Biosciences, Inc. (INBX) is a Great Choice
09-07-2026
yahoo.com
What is the current price of INHIBRX BIOSCIENCES INC (INBX:NASDAQ)?
The current price of INHIBRX BIOSCIENCES INC (INBX:NASDAQ) is $82.05.
INHIBRX BIOSCIENCES INC (INBX:NASDAQ) absolute price change since previous trading day?
The absolute price change of INHIBRX BIOSCIENCES INC (INBX:NASDAQ) since the previous trading day is $-2.68.
INHIBRX BIOSCIENCES INC (INBX:NASDAQ) percentage price change since previous trading day?
The percentage price change of INHIBRX BIOSCIENCES INC (INBX:NASDAQ) since the previous trading day is -3.163%.
What is the most recent average sentiment score for INHIBRX BIOSCIENCES INC (INBX:NASDAQ)?
The most recent average sentiment score for INHIBRX BIOSCIENCES INC (INBX:NASDAQ) is 69 out of 100.
What is the most recent average sentiment for INHIBRX BIOSCIENCES INC (INBX:NASDAQ)?
The most recent sentiment for INHIBRX BIOSCIENCES INC (INBX:NASDAQ) is .
SEC-8K** Filing Available For INHIBRX BIOSCIENCES INC (INBX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.